In accordance with clause 30 of the ABPI Code of Practice, the Mitsubishi Tanabe Pharma Group will disclose any engagements and interactions with members of the public, including journalists and patients on this page annually.
We have no interactions to disclose at this time.
Terms and Privacy
Contact Us
Mitsubishi TANABE Pharma Europe Ltd
Dashwood House
69 Old Broad Street
London
EC2M 1QS
United Kingdom